AI Clinical Trials Get $77M Vote of Confidence

Google Ventures just led a $77M round into AI-powered GI diagnostics — here's what it signals about where healthcare AI investment is heading

Why are pharma companies and top-tier VCs betting big on AI clinical trial networks?

Iterative Health just closed a $77 million Series C led by Google Ventures and Insight Partners — one of the largest rounds in GI diagnostic AI to date. The company's core product is an AI-powered endoscopy platform that detects colorectal polyps and lesions that human endoscopists miss, with published data showing significant improvement in adenoma detection rate, the primary quality metric in colorectal cancer screening.

📊 The funding is significant on its own. But the strategic signal it sends about where healthcare AI investment is heading in 2026 is more important than the dollar amount.

Google Ventures leading this round reflects a pattern that has become consistent in healthcare AI: the major technology platforms are moving from adjacent interest to direct investment in clinical AI companies. Google Health, Microsoft, and Amazon have all deepened their healthcare AI commitments in the last 18 mon…